stockrowPrecigen, Inc. (PGEN) vs Ultragenyx Pharmaceutical Inc. (RARE)
- Precigen, Inc. PGEN 4.43 +4.98%
- Ultragenyx Pharmaceutical Inc. RARE 15.49 −0.51%
Precigen, Inc. and Ultragenyx Pharmaceutical Inc. are both Biotechnology companies. Precigen, Inc. and Ultragenyx Pharmaceutical Inc. are of similar size ($1.5B and $1.5B). Ultragenyx Pharmaceutical Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against 15.8%. Precigen, Inc. has the higher net margin (15.6% vs −71.8%) and the higher return on invested capital (15.9% vs 0.00%). Across the 17 metrics below, Precigen, Inc. leads on 11 and Ultragenyx Pharmaceutical Inc. on 6.
Valuation
Profitability
| Metric | PGEN | RARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.42% | 82.88% | 68.51% |
| Operating margin | 21.43% | (63.97%) | 0.00% |
| Net margin | 15.55% | (71.78%) | 0.00% |
| Free cash flow margin | (47.35%) | (61.23%) | 0.00% |
| Return on equity | 38.84% | 285.68% | (51.96%) |
| Return on assets | 12.73% | (44.08%) | (46.06%) |
| Return on invested capital | 15.93% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack